Mutations of the tumor suppressor gene p53 have been found in hepatocellular carcinomas (HCCs) from many countries where HCC is common, but p53 mutations detected by direct sequencing in HCCs from the United States (where HCC is uncommon) have been reported only rarely. p53 Exons 1 to 11 were analyzed by polymerase chain reaction, single-strand conformation polymorphism analysis, and direct sequencing in HCCs from 12 patients from the United States and in adjacent non-tumorous liver from 10 of them. Abnormalities of the p53 gene were found in five of the 12 tumors, including mutations in exon 4 (one patient), exon 5 (one patient) and exon 8 (three patients). In all 12 tumors, a normal conformation of exon 7 was found; in five of these HCCs the absence of mutations was confirmed by direct sequencing. Thus, the mutations of p53 codon 249 that have frequently been found in HCCs from endemic areas apparently do not play a role in most HCCs in the United States. Since the mutations in codon 249 are thought to be due to aflatoxin ingestion, the data suggest that factors other than aflatoxin may be responsible for the p53 abnormalities in the patients from the USA.
Introduction
Integration of hepatitis B virus (HBV*) DNA and mutations of the tumor suppressor gene p53 have been associated with hepatocellular carcinoma (HCC) and may play a role in the development of this tumor (1). Nevertheless, the precise molecular mechanisms of hepatocarcinogenesis are still unclear.
The p53 gene plays a central role in the regulation of cell division, and mutations of this gene have been found in many human cancers including up to 50% of HCCs (2, 3) . The prevalence of p53 mutations in HCCs varies significantly between different geographic areas; p53 mutations have been found in as many as 56% of HCCs from Mozambique (4), 67% of HCCs from Senegal (5) and as few as none in HCCs from Australia (6) . In certain areas where dietary exposure to aflatoxin B, (AFB) is common, a G->T transversion at p53 codon 249 is the most common mutation found in HCCs (2, 3, 5) ; however, in HCCs from other regions, p53 mutations are scattered throughout exons 5-8 (the most highly conserved
•Abbreviations: HBV, hepatitis B virus; HCC, hepatocellular carcinoma; AFB, aflatoxin B^ PCR, polymerase chain reaction; SSCP, single-strand conformation polymorphism. and the most frequently studied exons of the p53 gene) (4, 5, (7) (8) (9) (10) (11) .
The analysis by direct sequencing of p53 alterations in HCCs from the USA has only rarely been reported, although immunohistochemical studies have suggested that mutations were present. In the present study, the status of the p53 gene was analyzed in HCCs and adjacent non-tumorous livers of patients from the USA; the entire coding sequence of the p53 gene (exons 1-11) was analyzed.
Materials and methods

Patients
HCCs from 12 patients and adjacent non-tumorous livers from 10 of them were obtained at surgery (eight patients) or autopsy (four patients). Nine patients had been born in the USA and the other three were from Korea and Laos and had been residents of the USA for at least 5 years (Table I ). All had been admitted to hospitals in Houston and Dallas, Texas. The patients included nine males and three females, ages 16-64 years; four were black, five were white and three were oriental. Three of 12 were HBsAg-positive and four of nine tested had anti-HCV. Detailed information on the patients is presented in Table I .
Polymerase chain reaction
Genomic DNA was isolated from HCC and non-tumorous liver by proteinase K digestion and phenol/chloroform extraction as described previously (12) . The DNA (50-100 ng) was amplified by polymerase chain reaction (PCR) (Perkin-Elmer-Cetus, Norwalk, CT). Primers to amplify fragments of the p53 gene from exon 1 to exon 11 (Table IT) were designed using Mac Vector software (IBI, New Haven, CT) (exons 1-3, 10-11), or were selected according to previously published information (exons 4-9) (11). (Only the coding region of exon 11 was examined.) PCR amplification (10 nl reaction volume) was performed in the presence of [ 32 P]dCTP for 35 cycles, each cycle consisting of 95°C for 1 min, 55°C for 1 min and 72°C for 1 min.
Single-strand conformation polymorphism
Single-strand conformation polymorphism (SSCP) analysis was performed on each PCR product (11, 13) . Each PCR product was mixed with 5 volumes of denaturing solution (95% formamide, 20 mM EDTA, 0.05% xylene cyanol, 0.05% bromphenol blue), heated for 3 min at 95°C, cooled on ice and subjected to non-denaturing electrophoresis in a 6% polyacrylamide gel in tris-borate buffer with or without 10% glycerol. The gels were run for 16-20 h at 300-500 V in a SequiGen electrophoretic chamber (BioRad Laboratories, Hercules, CA) either at room temperature or at 10-15°C. The gels were dried and exposed to X-ray film at -80"C DNA sequencing DNA sequencing was performed on any PCR product that showed a conformational change in SSCP analysis. (In addition, exon 7 was sequenced on selected HCC samples.) A fresh sample of DNA was prepared by PCR amplification of the original DNA and purified by preparative electrophoresis. Nucleotide sequences were determined by the dideoxy chain termination method (Sequenase 2, United States Biochemicals, Cleveland, OH) with modifications (14) . When the amount of the DNA template was limited, the double-stranded cycle sequencing method was used (fmol system, Promega, Madison, WI). Fragments were sequenced in two directions with sense and antisense primers. In some cases, PCR-amplified fragments were cloned by the TA cloning method prior to sequencing (Invitrogen, San Diego, CA), in order to obtain a more clear reading of the sequence. Computer analysis of mutations was performed utilizing a publicly available software package, 'Database and Software for the Analysis of Mutations in the Human p53 Gene' (15) .
Control testing
To determine whether SSCP could detect the 'hot spot' mutation in p53 exon 7 (at codon 249) that has been closely associated with HCC, the PLC/PRF/5 
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Results
Conformation and sequence analysis of p53 exons 1-11
Altered mobilities of single-stranded DNA fragments of the p53 gene were observed in five of 12 HCCs. The fragments with altered mobility were exon 4 (patient 7; Figure 1A ), exon 5-intron 5 (patient 1; Figure IB) , exons 8-9 (patients 12, 19, 21; Figure 1C ). In addition, alterations were also seen in the adjacent non-tumorous liver from one patient in a fragment containing intron 5-exon 6 (patient 7; not shown).
Exon 7 was normal by SSCP in every sample; this was further confirmed in five selected HCC samples by direct sequencing. The mobility of the fragment containing exon 7 was the same in HCC and non-tumorous liver in every patient. The electrophoretic conditions used for SSCP included those that have been reported to detect the greatest number of point mutations (13) . The SSCP method was shown here to be able to detect a point mutation which is known to be a G-»T transversion at codon 249 (exon 7) in a control HCC cell line, PLC/PRF/5; the exon 7 fragment from this control cell line had abnormal mobility by SSCP compared to the same exon from a normal liver. Sequencing of fragments with conformational changes showed single base-pair substitutions in HCCs of four patients, and multiple mutations in both HCC and non-tumorous liver 
GATC GATC GATC GATC
of one other patient (including a deletion in the tumor) ( Fig. 2 ; (Table HI) . These were accompanied by splice-site mutations in both HCC and liver in patient 7 ( Table TH) .
Comparison of the p53 mutations with the p53 database
The p53 mutations found in these patients were compared to those previously reported in the literature, utilizing a publicly available database (15) . Mutations in the patients in the present study (Table HI) were compared by codon and nucleotide position with published reports of p53 mutations in human HCCs and other tumors (Table TV) . Eight cases with mutations in p53 exons 5-8 in HCCs at the same codons as those found in the present study were identified in the database. The positions of the nucleotide substitutions seen in the present study, however, except the mutation in patient 21 (C-»T transition at codon 267), were unlike any previously published for HCCs (Table TV) .
Discussion
The locations of mutations within the p53 tumor suppressor gene differ in HCCs from different geographic regions; but the analysis of these mutations in HCC patients from the United States has only rarely been reported. In the present study, exons 1-11 of the p53 gene were analyzed in 12 HCCs from patients who had been born in (nine patients) or were long-time residents of (three patients) the United States.
Mutations of the p53 gene were found in five of 12 of the HCCs (42%), a prevalence that is similar to that reported by direct sequencing of p53 in HCCs from other countries (2, 3) and to the prevalence of presumed mutant p53 protein detected in HCC patients by immunohistochemistry in another study of patients from the United States (16) .
No alterations in exon 7 of the p53 gene were observed in these patients. This is consistent with the low prevalence of mutations at codon 249 reported in geographic areas where AFB is not detectable at high levels in the diet, such as Japan (17) , Germany (4), unspecified parts of Europe (7) and Australia (6) . These findings suggest that factors other than AFB may be responsible for the p53 abnormalities in the patients from the United States in the present study.
In the present study, the coding regions of all 11 exons were examined; mutations were found only in exons 4, 5 and 8. Most previous studies have analyzed only the highly conserved exons 5-8, although short segments of exons 2, 3 and 4 were reported to have no mutations in one study (18) . The importance to cell survival of the highly conserved exons 5-8 may be the reason why mutations in them are associated with a lifethreatening event such as the development of HCC.
Only one of the p53 mutations found in five patients in the present study had been reported previously in HCC (15). However, one of the mutation sites (codon 282) is a commonly mutated ('hot spot') p53 codon in other human cancers, such as colorectal and lung cancers. When the nucleotide contexts of mutated bases in the p53 gene reported in the literature (15) are analyzed, mutations occurring in a GGC or CGG sequence (in which the underlined base becomes mutated) are the ones most frequently reported in HCCs. (The frequently mutated G at the third position of codon 249 is responsible for the frequency of the first of these patterns.) This type of mutation was observed in two patients in the present study (patients 7 and 12; Table V ). This common pattern of p53 mutation in HCC, despite differences in the positions of the codons at which they occur, may reflect relatively common mechanisms of carcinogenesis that remain to be clarified.
G-»T transversion, like that found at codon 74 in patient 7, is likely to be caused by an exogenous carcinogen, such as aflatoxin. Aflatoxin causes primarily G-VT mutations in bacteria (19) , rats (leading to liver tumors) (20) and in the p53 gene of the human hepatoblastoma cell line Hep G2 (21) . In addition, the deletion at codons 74-77 in this patient may have occurred because of the 'runs' of 4 cytosines that are found in and near the deletion site, since small deletions commonly occur at tandem repeats of a single nucleotide (22) .
In two other patients, one can conjecture that the p53 mutation may have occurred by deamination of C-> T (patient 21; in patient 12, the G->A mutation may reflect deamination of C in the opposite strand) (23) . Theoretically, increased levels of nitric oxide in hepatocytes due to the inflammation of hepatitis (24) could cause deamination of DNA (25) and inhibition of a DNA repair enzyme (26) .
It is not clear whether all of the mutations described here would inactivate the p53 protein. The deletion resulting in a frameshift in exon 4 in patient 7 would result in synthesis of a truncated protein lacking the p53 functional domains responsible for DNA binding, nuclear transportation, and oligomerization. Four other mutations (in patients 1, 12, 19 and 21) were found in regions overlapping the domain of p53 responsible for sequence-specific DNA binding (27) . These observations suggest that the mutations found in these patients would significantly affect p53 function and, therefore, might contribute to HCC development.
